Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 25,000 shares at $51.46 ($1.3M) on 2023-12-26, disclosed to the SEC on 2023-12-28.
Scheduled sale ($1.3M) by EVP, Chf Clinical Develop Ofcr under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |